{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:29:49Z","timestamp":1791300589922,"version":"4.1.0"},"reference-count":82,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"vor","delay-in-days":365,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["309093\/2013-9"],"award-info":[{"award-number":["309093\/2013-9"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["7481\/2011"],"award-info":[{"award-number":["7481\/2011"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fundo de Incentivo \u00e0 Pesquisa e Eventos","award":["14-0506"],"award-info":[{"award-number":["14-0506"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.bbadis.2016.05.021","type":"journal-article","created":{"date-parts":[[2016,5,29]],"date-time":"2016-05-29T14:00:51Z","timestamp":1464530451000},"page":"1608-1616","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Oxidative and nitrative stress and pro-inflammatory cytokines in Mucopolysaccharidosis type II patients: effect of long-term enzyme replacement therapy and relation with glycosaminoglycan accumulation"],"prefix":"10.1016","volume":"1862","author":[{"given":"Carlos Eduardo Diaz","family":"Jacques","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruna","family":"Donida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline P.","family":"Mescka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiane G.B.","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desir\u00e8e P.","family":"Marchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda H.","family":"Bitencourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maira G.","family":"Burin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina F.M.","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Giugliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen Regla","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2016.05.021_bb0005","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"3421","article-title":"The mucopolysaccharidoses","author":"Neufeld","year":"2001"},{"key":"10.1016\/j.bbadis.2016.05.021_bb0010","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.pediatrneurol.2004.10.009","article-title":"Mucopolysaccharidosis type II in females: case report and review of literature","volume":"32","author":"Tuschl","year":"2005","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.bbadis.2016.05.021_bb0015","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1750-1172-8-92","article-title":"Clinical manifestations in female carriers of mucopolysaccharidosis type II: a Spanish cross-sectional study","volume":"8","author":"Guill\u00e9n-Navarro","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.bbadis.2016.05.021_bb0020","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ejmg.2012.11.006","article-title":"Mucopolysaccharidosis type II in a female carrying a heterozygous stop mutation of the iduronate-2-sulfatase gene and showing a skewed X chromosome inactivation","volume":"56","author":"Pi\u00f1a-Aguilar","year":"2013","journal-title":"Eur. J. Med. Genet."},{"key":"10.1016\/j.bbadis.2016.05.021_bb0025","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1002\/ajmg.a.32320","article-title":"Mucopolysaccharidoses in Brazil: what happens from birth to biochemical diagnosis?","volume":"146","author":"Vieira","year":"2008","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.bbadis.2016.05.021_bb0030","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1542\/peds.2007-1350","article-title":"Recognition and diagnosis of mucopolysaccharidosis II (hunter syndrome)","volume":"121","author":"Martin","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.bbadis.2016.05.021_bb0035","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1136\/jmg.19.6.408","article-title":"A clinical and genetic study of Hunter's syndrome 2: differences between the mild and severe forms","volume":"19","author":"Young","year":"1982","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.bbadis.2016.05.021_bb0040","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s10545-010-9093-7","article-title":"The birth prevalence of lysosomal storage disorders in the Czech Republic: comparison with data in different populations","volume":"33","author":"Poup\u011btov\u00e1","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bbadis.2016.05.021_bb0045","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/ajmg.a.20314","article-title":"Incidence of the mucopolysaccharidoses in Western Australia","volume":"123","author":"Nelson","year":"2003","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.bbadis.2016.05.021_bb0050","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s10545-005-0112-z","article-title":"Cumulative incidence rates of the mucopolysaccharidoses in Germany","volume":"28","author":"Baehner","year":"2005","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bbadis.2016.05.021_bb0055","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/sj.ejhg.5201044","article-title":"Prevalence of lysosomal storage diseases in Portugal","volume":"12","author":"Pinto","year":"2004","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.bbadis.2016.05.021_bb0060","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s004399900075","article-title":"The frequency of lysosomal storage diseases in The Netherlands","volume":"105","author":"Poorthuis","year":"1999","journal-title":"Hum. Genet."},{"key":"10.1016\/j.bbadis.2016.05.021_bb0065","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1007\/s004310050685","article-title":"Selective screening of 10,000 high-risk Brazilian patients for the detection of inborn errors of metabolism","volume":"156","author":"Coelho","year":"1997","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.bbadis.2016.05.021_bb0070","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ymgme.2009.08.006","article-title":"Japan Elaprase\u00ae treatment (JET) study: idursulfase enzyme replacement therapy in adult patients with attenuated Hunter syndrome (mucopolysaccharidosis II, MPS II)","volume":"99","author":"Okuyama","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbadis.2016.05.021_bb0075","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/01.gim.0000232477.37660.fb","article-title":"A phase II\/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome)","volume":"8","author":"Muenzer","year":"2006","journal-title":"Genet. Med."},{"key":"10.1016\/j.bbadis.2016.05.021_bb0080","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ymgme.2006.09.001","article-title":"A phase I\/II clinical trial of enzyme replacement therapy in mucopolysaccharidosis II (Hunter syndrome)","volume":"90","author":"Muenzer","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbadis.2016.05.021_bb0085","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00431-007-0635-4","article-title":"Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy","volume":"167","author":"Wraith","year":"2008","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.bbadis.2016.05.021_bb0090","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/GIM.0b013e318206786f","article-title":"Idursulfase treatment of Hunter syndrome in children younger than 6years: results from the Hunter Outcome Survey","volume":"13","author":"Muenzer","year":"2011","journal-title":"Genet. Med."},{"key":"10.1016\/j.bbadis.2016.05.021_bb0095","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/8904_2013_289","article-title":"Enzyme replacement therapy in mucopolysaccharidosis II patients under 1year of age","volume":"14","author":"Lampe","year":"2014","journal-title":"JIMD Rep."},{"key":"10.1016\/j.bbadis.2016.05.021_bb0100","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/gim.2013.162","article-title":"A multicenter, open-label study evaluating safety and clinical outcomes in children (1.4\u20137.5years) with Hunter syndrome receiving idursulfase enzyme replacement therapy","volume":"16","author":"Giugliani","year":"2014","journal-title":"Genet. Med."},{"key":"10.1016\/j.bbadis.2016.05.021_bb0105","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ymgme.2011.02.016","article-title":"Oxidative stress in patients with mucopolysaccharidosis type II before and during enzyme replacement therapy","volume":"103","author":"Filippon","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbadis.2016.05.021_bb0110","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.cca.2007.09.008","article-title":"Mutational and oxidative stress analysis in patients with mucopolysaccharidosis type I undergoing enzyme replacement therapy","volume":"387","author":"Pereira","year":"2008","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.bbadis.2016.05.021_bb0115","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.bbadis.2015.02.004","article-title":"Oxidative stress and inflammation in mucopolysaccharidosis type IVA patients treated with enzyme replacement therapy","volume":"1852","author":"Donida","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2016.05.021_bb0120","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s11011-006-9030-5","article-title":"Evidence that oxidative stress is increased in plasma from patients with maple syrup urine disease","volume":"21","author":"Barschak","year":"2006","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.bbadis.2016.05.021_bb0125","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10571-008-9313-y","article-title":"l-Carnitine blood levels and oxidative stress in treated phenylketonuric patients","volume":"29","author":"Sitta","year":"2009","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.bbadis.2016.05.021_bb0130","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1080\/15216540600904885","article-title":"Lysosomal labilization","volume":"58","author":"Terman","year":"2006","journal-title":"IUBMB Life"},{"key":"10.1016\/j.bbadis.2016.05.021_bb0135","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1089\/ars.2006.8.197","article-title":"Oxidative stress, accumulation of biological \u2018garbage\u2019, and aging","volume":"8","author":"Terman","year":"2006","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bbadis.2016.05.021_bb0140","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.brainres.2009.03.071","article-title":"Mucopolysaccharidosis IIIB: oxidative damage and cytotoxic cell involvement in the neuronal pathogenesis","volume":"1279","author":"Villani","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.bbadis.2016.05.021_bb0145","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1104\/pp.106.077073","article-title":"Reactive species and antioxidants redox biology is a fundamental theme of aerobic life","volume":"141","author":"Halliwell","year":"2006","journal-title":"Plant Physiol."},{"key":"10.1016\/j.bbadis.2016.05.021_bb0150","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1073\/pnas.252784899","article-title":"Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIB","volume":"100","author":"Ohmi","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2016.05.021_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10545-013-9613-3","article-title":"Mucopolysaccharide diseases: a complex interplay between neuroinflammation, microglial activation and adaptive immunity","volume":"37","author":"Archer","year":"2014","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bbadis.2016.05.021_bb0160","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.mrgentox.2011.02.005","article-title":"DNA damage in leukocytes from pretreatment mucopolysaccharidosis type II patients: protective effect of enzyme replacement therapy","volume":"721","author":"Filippon","year":"2011","journal-title":"Mutat. Res."},{"key":"10.1016\/j.bbadis.2016.05.021_bb0165","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","article-title":"Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction","volume":"95","author":"Ohkawa","year":"1979","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bbadis.2016.05.021_bb0170","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/0076-6879(90)86141-H","article-title":"Determination of carbonyl content in oxidatively modified proteins","volume":"186","author":"Levine","year":"1990","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.bbadis.2016.05.021_bb0175","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0304-3940(01)01636-6","article-title":"Changes in thiol content and expression of glutathione redox system genes in the hippocampus and cerebellum in Alzheimer's disease","volume":"302","author":"Aksenov","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbadis.2016.05.021_bb0180","doi-asserted-by":"crossref","first-page":"344","DOI":"10.5414\/CNP58344","article-title":"Correlative studies of urine fluorescence and free radical indicators","volume":"58","author":"Kirschbaum","year":"2002","journal-title":"Clin. Nephrol."},{"key":"10.1016\/j.bbadis.2016.05.021_bb0185","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0076-6879(84)05016-3","article-title":"Catalase in vitro","volume":"105","author":"Aebi","year":"1984","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.bbadis.2016.05.021_bb0190","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S0076-6879(85)13062-4","article-title":"Glutathione reductase","volume":"113","author":"Carlberg","year":"1985","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.bbadis.2016.05.021_bb0195","first-page":"347","article-title":"Reduced glutathione and glutathione disulfide","volume":"108","author":"Browne","year":"1998","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bbadis.2016.05.021_bb0200","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/clinchem\/38.6.803","article-title":"Measuring urinary glycosaminoglycans in the presence of protein: an improved screening procedure for mucopolysaccharidoses based on dimethylmethylene blue","volume":"38","author":"de Jong","year":"1992","journal-title":"Clin. Chem."},{"key":"10.1016\/j.bbadis.2016.05.021_bb0205","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2016.05.021_bb0210","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nrm1423","article-title":"The cell biology of lysosomal storage disorders","volume":"5","author":"Futerman","year":"2004","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbadis.2016.05.021_bb0215","doi-asserted-by":"crossref","first-page":"20423","DOI":"10.1074\/jbc.R110.134452","article-title":"Common and uncommon pathogenic cascades in lysosomal storage diseases","volume":"285","author":"Vitner","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2016.05.021_bb0220","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s10545-015-9861-5","article-title":"Redox signalling and mitochondrial stress responses; lessons from inborn errors of metabolism","volume":"38","author":"Olsen","year":"2015","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bbadis.2016.05.021_bb0225","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.redox.2014.02.006","article-title":"Hydrogen peroxide sensing, signaling and regulation of transcription factors","volume":"2","author":"Marinho","year":"2014","journal-title":"Redox Biol."},{"key":"10.1016\/j.bbadis.2016.05.021_bb0230","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1042\/BJ20111752","article-title":"Cell signalling by reactive lipid species: new concepts and molecular mechanisms","volume":"442","author":"Higdon","year":"2012","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbadis.2016.05.021_bb0235","series-title":"Free Radicals in Biology and Medicine","author":"Halliwell","year":"2007"},{"key":"10.1016\/j.bbadis.2016.05.021_bb0240","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1749-6632.1999.tb08633.x","article-title":"Free radicals and hearing: cause, consequence, and criteria","volume":"884","author":"Evans","year":"1999","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbadis.2016.05.021_bb0245","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijdevneu.2015.03.004","article-title":"Protective effect of antioxidants on DNA damage in leukocytes from X-linked adrenoleukodystrophy patients","volume":"43","author":"Marchetti","year":"2015","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.bbadis.2016.05.021_bb0250","article-title":"Oxidative stress in patients with X-linked Adrenoleukodystrophy","volume":"1-16","author":"Deon","year":"2015","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.bbadis.2016.05.021_bb0255","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s10571-013-0002-0","article-title":"Neurological damage in MSUD: the role of oxidative stress","volume":"34","author":"Sitta","year":"2014","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.bbadis.2016.05.021_bb0260","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1179\/135100001101536094","article-title":"Lysosomal involvement in apoptosis","volume":"6","author":"Brunk","year":"2001","journal-title":"Redox Rep."},{"key":"10.1016\/j.bbadis.2016.05.021_bb0265","doi-asserted-by":"crossref","first-page":"3778","DOI":"10.1046\/j.1432-1033.2003.03765.x","article-title":"Lysosomal enzymes promote mitochondrial oxidant production, cytochrome c release and apoptosis","volume":"270","author":"Zhao","year":"2003","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bbadis.2016.05.021_bb0270","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1089\/ars.2012.4885","article-title":"Lysosomal iron, iron chelation, and cell death","volume":"18","author":"Terman","year":"2013","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bbadis.2016.05.021_bb0275","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.bbadis.2011.11.001","article-title":"Globotriaosylceramide is correlated with oxidative stress and inflammation in Fabry patients treated with enzyme replacement therapy","volume":"1822","author":"Biancini","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2016.05.021_bb0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0003-2697(90)90002-Q","article-title":"Noncyclooxygenase oxidative formation of a series of novel prostaglandins: analytical ramifications for measurement of eicosanoids","volume":"184","author":"Morrow","year":"1990","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bbadis.2016.05.021_bb0285","doi-asserted-by":"crossref","first-page":"24441","DOI":"10.1074\/jbc.274.35.24441","article-title":"Isoprostanes: formation, analysis and use as indices of lipid peroxidation in vivo","volume":"274","author":"Lawson","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2016.05.021_bb0290","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1089\/152308601300185241","article-title":"The importance of proteins in defense against oxidation","volume":"3","author":"Bourdon","year":"2001","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bbadis.2016.05.021_bb0295","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1582-4934.2006.tb00407.x","article-title":"Protein carbonylation, cellular dysfunction, and disease progression","volume":"10","author":"Dalle-Donne","year":"2006","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.bbadis.2016.05.021_bb0300","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ymgme.2009.06.007","article-title":"Profiling of oxidative stress in patients with inborn errors of metabolism","volume":"98","author":"Mc Guire","year":"2009","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbadis.2016.05.021_bb0305","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1021\/tx060061w","article-title":"Nitroxidative, nitrosative, and nitrative stress: kinetic predictions of reactive nitrogen species chemistry under biological conditions","volume":"19","author":"Lancaster","year":"2006","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.bbadis.2016.05.021_bb0310","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00726-003-0014-z","article-title":"Dityrosine as a product of oxidative stress and fluorescent probe","volume":"25","author":"Malencik","year":"2003","journal-title":"Amino Acids"},{"key":"10.1016\/j.bbadis.2016.05.021_bb0315","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00726-003-0018-8","article-title":"Peroxynitrite reactivity with amino acids and proteins","volume":"25","author":"Alvarez","year":"2003","journal-title":"Amino Acids"},{"key":"10.1016\/j.bbadis.2016.05.021_bb0320","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1042\/bj3220167","article-title":"Pathways of peroxynitrite oxidation of thiol groups","volume":"322","author":"Quijano","year":"1997","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbadis.2016.05.021_bb0325","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1006\/abbi.1995.1303","article-title":"Tyrosine modification by reactive nitrogen species: a closer look","volume":"319","author":"van der Vliet","year":"1995","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bbadis.2016.05.021_bb0330","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0014-5793(94)80391-9","article-title":"Aromatic hydroxylation and nitration of phenylalanine and tyrosine by peroxynitrite. Evidence for hydroxyl radical production from peroxynitrite","volume":"339","author":"van der Vliet","year":"1994","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbadis.2016.05.021_bb0335","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0014-5793(95)00307-U","article-title":"Peroxynitrite-mediated oxidative protein modifications","volume":"364","author":"Ischiropoulos","year":"1995","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbadis.2016.05.021_bb0340","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF02536182","article-title":"Redox cycling of iron and lipid peroxidation","volume":"27","author":"Minotti","year":"1992","journal-title":"Lipids"},{"key":"10.1016\/j.bbadis.2016.05.021_bb0345","doi-asserted-by":"crossref","first-page":"10282","DOI":"10.1016\/S0021-9258(18)67521-0","article-title":"The involvement of iron in lipid peroxidation. Importance of ferric to ferrous ratios in initiation","volume":"261","author":"Braughler","year":"1986","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2016.05.021_bb0350","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0076-6879(94)34095-1","article-title":"Total antioxidant status in plasma and body fluids","volume":"234","author":"Rice-Evans","year":"1994","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.bbadis.2016.05.021_bb0355","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3109\/10715769709097799","article-title":"Factors influencing the antioxidant activity determined by the ABTS+ radical cation assay","volume":"26","author":"Miller","year":"1997","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.bbadis.2016.05.021_bb0360","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2353\/ajpath.2008.070564","article-title":"Mechanism of glycosaminoglycan-mediated bone and joint disease: implications for the mucopolysaccharidoses and other connective tissue diseases","volume":"172","author":"Simonaro","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbadis.2016.05.021_bb0365","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ymgme.2011.01.015","article-title":"Neuroinflammatory and oxidative stress phenomena in MPS IIIA mouse model: the positive effect of long-term aspirin treatment","volume":"103","author":"Arfi","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbadis.2016.05.021_bb0370","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/jnr.21134","article-title":"Cytokines, neurotrophins, and oxidative stress in brain disease from mucopolysaccharidosis IIIB","volume":"85","author":"Villani","year":"2007","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbadis.2016.05.021_bb0375","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ymgme.2016.01.012","article-title":"Elevated TNF-\u03b1 is associated with pain and physical disability in mucopolysaccharidosis types I, II and VI","volume":"117","author":"Polgreen","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbadis.2016.05.021_bb0380","first-page":"62","article-title":"Nitric oxide-dependent regulation of pro-inflammatory cytokines in group B streptococcal inflammation of rat lung","volume":"33","author":"Raykova","year":"2003","journal-title":"Ann. Clin. Lab. Sci."},{"key":"10.1016\/j.bbadis.2016.05.021_bb0385","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1006\/cyto.1996.0147","article-title":"Relation between pro- and anti-inflammatory cytokines and the production of nitric oxide (NO) in severe sepsis","volume":"9","author":"Groeneveld","year":"1997","journal-title":"Cytokine"},{"key":"10.1016\/j.bbadis.2016.05.021_bb0390","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3346\/jkms.2006.21.4.733","article-title":"Upregulation of proinflammatory cytokines in the fetal brain of the Gaucher mouse","volume":"21","author":"Hong","year":"2006","journal-title":"J. Korean Med. Sci."},{"key":"10.1016\/j.bbadis.2016.05.021_bb0395","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1189\/jlb.0310149","article-title":"The regulatory role of nitric oxide in proinflammatory cytokine expression during the induction and resolution of inflammation","volume":"88","author":"Kobayashi","year":"2010","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bbadis.2016.05.021_bb0400","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.4049\/jimmunol.166.6.3873","article-title":"Biphasic regulation of NF-kappa B activity underlies the pro- and anti-inflammatory actions of nitric oxide","volume":"166","author":"Connelly","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbadis.2016.05.021_bb0405","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1074\/jbc.M211642200","article-title":"Nuclear factor-kappa B and mitogen-activated protein kinases mediate nitric oxide-enhanced transcriptional expression of interferon-beta","volume":"278","author":"Jacobs","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2016.05.021_bb0410","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10565-014-9284-3","article-title":"Glycosaminoglycans can be associated with oxidative damage in mucopolysaccharidosis II patients submitted to enzyme replacement therapy","volume":"30","author":"Negretto","year":"2014","journal-title":"Cell Biol. Toxicol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443916301387?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443916301387?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T20:36:30Z","timestamp":1656621390000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443916301387"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":82,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0925443916301387"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2016.05.021","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oxidative and nitrative stress and pro-inflammatory cytokines in Mucopolysaccharidosis type II patients: effect of long-term enzyme replacement therapy and relation with glycosaminoglycan accumulation","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2016.05.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V.","name":"copyright","label":"Copyright"}]}}